Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Matthieu Grusse"'
Autor:
Grigorios T. Gerotziafas, Patrick Van Dreden, Theodoros N. Sergentanis, Marianna Politou, Aurélie Rousseau, Matthieu Grusse, Michèle Sabbah, Ismail Elalamy, Vasiliki Pappa, Tina Skourti, Tina Bagratuni, Ioannis Ntanasis-Stathopoulos, Eleni Korompoki, Stavroula Labropoulou, Meletios A. Dimopoulos, Evangelos Terpos
Publikováno v:
Hemato, Vol 3, Iss 1, Pp 111-121 (2022)
Background. Hypercoagulable state and endothelial cell activation are common alterations in patients with COVID-19. Nevertheless, the hypothesis of persistent hypercoagulability and endothelial cell activation following recovery from COVID-19 remains
Externí odkaz:
https://doaj.org/article/0d5a096b45db44fabda36316d908c492
Autor:
Patrick Van Dreden PhD, Eleftheria Lefkou MD, PhD, Aboubakar Ka MSc, Konstantinos Sfakianoudis MD, Aurélie Rousseau PhD, Matthieu Grusse MSc, Ismail Elalamy MD, PhD, Grigoris T Gerotziafas MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Background The ROADMAP-EOP study aimed to identify clinically relevant biomarkers of hypercoagulability for the identification of pregnant women at risk of early onset preeclampsia worsening. Methods The ROADMAP-EOP observational single center retros
Externí odkaz:
https://doaj.org/article/b287f899fd0e462bae436ca6541fa184
Autor:
Grigoris T. Gerotziafas, Patrick Van Dreden, Emmanuelle Mathieu d’Argent, Eleftheria Lefkou, Matthieu Grusse, Marjorie Comtet, Rabiatou Sangare, Hela Ketatni, Annette K. Larsen, Ismail Elalamy
Publikováno v:
Thrombosis Journal, Vol 15, Iss 1, Pp 1-11 (2017)
Abstract Background Blood coagulation plays a crucial role in the blastocyst implantation process and its alteration may be related to in vitro fertilization (IVF) failure. We conducted a prospective observational longitudinal study in women eligible
Externí odkaz:
https://doaj.org/article/0a87ca49489149539c285a5c1cf85808
Autor:
Patrick Van Dreden, Evangelos Terpos, Marianna Politou, Meletios A. Dimopoulos, Matthieu Grusse, Grigorios T. Gerotziafas
Publikováno v:
Blood. 140:2783-2785
Autor:
Patrick Van Dreden, Salahdin Khelifi Otmane, Grigorios T. Gerotziafas, Matthieu Grusse, Aurélie Rousseau, Lila Louadj, Michele Sabbah
Publikováno v:
Blood. 140:5649-5650
Autor:
Patrick Van Dreden, Ismail Elalamy, Laurent Garderet, Grigoris T. Gerotziafas, Matthieu Grusse, Loula Papageorgiou
Publikováno v:
Blood. 136:4-4
Introduction: Multiple myeloma (MM) is an hematological disease linked to a high thrombotic risk, estimated at around 10%/year, irrespective to disease onset. An important proportion of MM patients presents at least one of the well-defined vascular r
Autor:
Hela Ketatni, Matthieu Grusse, Annette K. Larsen, Marjorie Comtet, Grigoris T. Gerotziafas, Ismail Elalamy, Patrick Van Dreden, Emmanuelle Mathieu d’Argent, Eleftheria Lefkou, Rabiatou Sangare
Publikováno v:
Thrombosis Journal
Thrombosis Journal, Vol 15, Iss 1, Pp 1-11 (2017)
Thrombosis Journal, Vol 15, Iss 1, Pp 1-11 (2017)
Background Blood coagulation plays a crucial role in the blastocyst implantation process and its alteration may be related to in vitro fertilization (IVF) failure. We conducted a prospective observational longitudinal study in women eligible for IVF
Autor:
Annette K. Larsen, Loula Papageorgiou, Meletios A. Dimopoulos, Theodora Psaltopoulou, Patrick Van Dreden, Evangelos Terpos, Theodoros N. Sergentanis, Grigorios T. Gerotziafas, Stella Salta, Matthieu Grusse, Despina Fotiou, Ismail Elalamy
Publikováno v:
Blood. 132:2014-2014
Background:Despite an increasing number of approved therapies, multiple myeloma (MM) remains an incurable disease with frequent drug resistsance. Resistance-mediating alterations are preexisting in early disease, and it is the selective pressure of a
Decreased levels of procoagulant phospholipids in bleeding patients treated by vitamin K antagonists
Autor:
Jerome Aulagnier, Patrick Van Dreden, Dominique François, Emmanuel Mathieu, Matthieu Grusse, Jean-François Dreyfus, Marc Vasse
Publikováno v:
Thrombosis research. 137
International Normalized Ratio (INR) is currently used to monitor vitamin K antagonist therapy, and the bleeding incidence becomes exponential for INR>4.5. Inversely, more than 50% of patients with a supratherapeutic INR are asymptomatic. Therefore i
Autor:
Patrick Van Dreden, Sophie Hillaire, Dominique François, Marc Vasse, Catherine Gorin, Matthieu Grusse
Publikováno v:
Blood. 126:1094-1094
Background: Despite reduced coagulation factors, it was recently described that patients with cirrhosis have an increased thrombotic tendency. Therefore, assays predicting the risk of bleeding or thrombosis are needed. Aims: As the Tissue Factor (TF)